Kentucky Retirement Systems Sells 977 Shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Kentucky Retirement Systems reduced its position in Walgreens Boots Alliance, Inc. (NASDAQ:WBAFree Report) by 1.7% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 57,372 shares of the pharmacy operator’s stock after selling 977 shares during the quarter. Kentucky Retirement Systems’ holdings in Walgreens Boots Alliance were worth $1,498,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds have also recently made changes to their positions in the company. New York Life Investment Management LLC raised its stake in Walgreens Boots Alliance by 0.4% in the 3rd quarter. New York Life Investment Management LLC now owns 114,506 shares of the pharmacy operator’s stock valued at $2,547,000 after acquiring an additional 499 shares during the period. Fulton Bank N.A. raised its position in shares of Walgreens Boots Alliance by 0.5% in the fourth quarter. Fulton Bank N.A. now owns 107,071 shares of the pharmacy operator’s stock valued at $2,796,000 after purchasing an additional 523 shares during the period. Insight Folios Inc lifted its stake in shares of Walgreens Boots Alliance by 5.8% during the 4th quarter. Insight Folios Inc now owns 9,640 shares of the pharmacy operator’s stock valued at $252,000 after buying an additional 525 shares in the last quarter. Pinnacle Financial Partners Inc boosted its holdings in Walgreens Boots Alliance by 4.9% in the 4th quarter. Pinnacle Financial Partners Inc now owns 11,866 shares of the pharmacy operator’s stock worth $310,000 after buying an additional 555 shares during the period. Finally, Westpac Banking Corp grew its stake in Walgreens Boots Alliance by 10.1% in the 4th quarter. Westpac Banking Corp now owns 6,100 shares of the pharmacy operator’s stock valued at $159,000 after buying an additional 560 shares in the last quarter. 58.59% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

Several research firms have issued reports on WBA. Leerink Partnrs restated a “market perform” rating on shares of Walgreens Boots Alliance in a research report on Monday, February 26th. SVB Leerink dropped their price objective on Walgreens Boots Alliance from $23.00 to $22.00 and set a “market perform” rating on the stock in a report on Monday, March 18th. Truist Financial reaffirmed a “hold” rating and set a $25.00 target price on shares of Walgreens Boots Alliance in a report on Monday, April 1st. UBS Group decreased their price target on Walgreens Boots Alliance from $25.00 to $22.00 and set a “neutral” rating on the stock in a research report on Wednesday, April 3rd. Finally, Bank of America cut their price objective on shares of Walgreens Boots Alliance from $23.00 to $22.00 and set an “underperform” rating for the company in a research report on Tuesday, March 26th. Four research analysts have rated the stock with a sell rating, ten have issued a hold rating and two have assigned a buy rating to the stock. According to data from MarketBeat, Walgreens Boots Alliance currently has a consensus rating of “Hold” and a consensus target price of $24.36.

Check Out Our Latest Stock Report on WBA

Walgreens Boots Alliance Price Performance

Shares of NASDAQ:WBA opened at $17.82 on Tuesday. Walgreens Boots Alliance, Inc. has a one year low of $17.12 and a one year high of $32.89. The company has a debt-to-equity ratio of 0.50, a current ratio of 0.66 and a quick ratio of 0.32. The firm has a market capitalization of $15.37 billion, a price-to-earnings ratio of -2.55, a PEG ratio of 1.13 and a beta of 0.80. The company’s fifty day moving average price is $18.84 and its 200-day moving average price is $21.30.

Walgreens Boots Alliance (NASDAQ:WBAGet Free Report) last released its earnings results on Thursday, March 28th. The pharmacy operator reported $1.20 EPS for the quarter, beating analysts’ consensus estimates of $0.82 by $0.38. Walgreens Boots Alliance had a positive return on equity of 12.11% and a negative net margin of 4.18%. The business had revenue of $37.05 billion for the quarter, compared to analysts’ expectations of $35.86 billion. During the same quarter in the prior year, the firm earned $1.16 earnings per share. The firm’s revenue was up 6.3% on a year-over-year basis. On average, equities research analysts anticipate that Walgreens Boots Alliance, Inc. will post 3.23 earnings per share for the current fiscal year.

Walgreens Boots Alliance Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, June 12th. Shareholders of record on Tuesday, May 21st will be paid a $0.25 dividend. This represents a $1.00 annualized dividend and a yield of 5.61%. The ex-dividend date of this dividend is Monday, May 20th. Walgreens Boots Alliance’s dividend payout ratio is currently -14.29%.

Insiders Place Their Bets

In other Walgreens Boots Alliance news, Director Inderpal S. Bhandari purchased 3,000 shares of the stock in a transaction on Thursday, April 11th. The stock was acquired at an average cost of $18.05 per share, with a total value of $54,150.00. Following the completion of the purchase, the director now directly owns 3,000 shares of the company’s stock, valued at approximately $54,150. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. In related news, Director Inderpal S. Bhandari purchased 3,000 shares of the firm’s stock in a transaction on Thursday, April 11th. The shares were acquired at an average cost of $18.05 per share, with a total value of $54,150.00. Following the purchase, the director now directly owns 3,000 shares of the company’s stock, valued at $54,150. The purchase was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, CFO Manmohan Mahajan acquired 6,000 shares of the stock in a transaction on Tuesday, April 2nd. The stock was bought at an average price of $19.38 per share, with a total value of $116,280.00. Following the transaction, the chief financial officer now directly owns 166,969 shares of the company’s stock, valued at approximately $3,235,859.22. The disclosure for this purchase can be found here. Insiders own 17.40% of the company’s stock.

About Walgreens Boots Alliance

(Free Report)

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.

Featured Articles

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance, Inc. (NASDAQ:WBAFree Report).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.